Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris Inc. to Release First Quarter 2022 Financial Results on May 9, 2022
06:59am, Friday, 08'th Apr 2022
PITTSBURGH , April 8, 2022 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) plans to release its first quarter 2022 financial results on Monday, May 9, before the open of the U.S. financial markets. Chie
Viatris (VTRS) Up 10.2% Since Last Earnings Report: Can It Continue?
12:47pm, Wednesday, 30'th Mar 2022
Viatris (VTRS) reported earnings 30 days ago. What's next for the stock?
2 Dirt Cheap Dividend Stocks to Buy Right Now
11:00am, Tuesday, 29'th Mar 2022
These two bargain stocks look like steals right now.
7 Cheap Stocks to Buy Now if You Have $100 to Spend
10:06am, Tuesday, 22'nd Mar 2022
The S&P 500 is off to a forgettable start this year, but that creates multiple buying opportunities if you're looking for cheap stocks. The post 7 Cheap Stocks to Buy Now if You Have $100 to Spend app
3 Dividend Stocks That Could Soar 34% to 54%, According to Wall Street
05:58am, Sunday, 20'th Mar 2022
The stocks have fallen quite a bit, but analysts look for strong rebounds.
Viatris Inc. (VTRS) CEO Mike Goettler Presents at 2022 Barclays Global Healthcare Conference (Transcript)
06:04pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Viatris CEO, director buy shares worth ~$520K
05:26pm, Wednesday, 16'th Mar 2022 Seeking Alpha
Viatris (VTRS) on Tuesday disclosed that its CEO and director bought ~53.1K shares at $9.78-9.97 worth ~$520K.CEO Michael Goettler bought ~50.4K shares at $9.78-9.97
Viatris Inc. (VTRS) CEO Mike Goettler Presents at 2022 Barclays Global Healthcare Conference (Transcript)
02:04pm, Wednesday, 16'th Mar 2022
Viatris Inc. (VTRS) CEO Mike Goettler Presents at 2022 Barclays Global Healthcare Conference (Transcript)
Viatris wins FDA approval for first generic of AstraZeneca’s Symbicort
08:18pm, Tuesday, 15'th Mar 2022 Seeking Alpha
Viatris (VTRS) shares are trading marginally higher in the post-market Tuesday after the U.S
Viatris (VTRS) Gains But Lags Market: What You Should Know
07:33pm, Tuesday, 15'th Mar 2022
Viatris (VTRS) closed the most recent trading day at $9.96, moving +1.53% from the previous trading session.
Why is Viatris (VTRS) Stock Down 25% in the Year So Far?
03:48pm, Friday, 11'th Mar 2022
Viatris (VTRS) stock drops 25% in the year so far as investors do not seem to be impressed by the impending sale of its biosimilar business.
Viatris: Takeaways From Management At The Raymond James Conference
11:36pm, Thursday, 10'th Mar 2022 Seeking AlphaViatris: Takeaways From Management At The Raymond James Conference
06:36pm, Thursday, 10'th Mar 2022
Did the biosimilars deal because they saw business slowing and wanted to create a low cost vertically-integrated player.
Is Viatris Stock in Trouble?
03:00pm, Thursday, 10'th Mar 2022 The Motley Fool
The stock crashed after the company reported earnings.
Viatris price target lowered at Citi following Biocon deal and earnings
01:36pm, Thursday, 10'th Mar 2022 Seeking Alpha
Citi has trimmed the price target of Viatris (VTRS) by as much as 31% in the wake of the generic drugmaker''s deal to sell its biosimilar assets to India-based Biocon Biologics and…
